Frederik Marmé

Arzt

Born: 1974

Has participated in:

A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
ABC3 Consensus Commented from the Perspective of the German Guidelines : Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine
Predictive factors in HER2-positive early breast cancer : endogenous HER2-specific immune response as an early predictive marker for pathologic complete response and disease-free survival

All Objects (62)

External links:

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Frederik Marmé

Has participated in:

External links:

Reset password